Abstracts are now being accepted for the upcoming Geothermal Rising Conference taking place in Reno, Nevada on 26-29 October ...
Data from the EMBARK trial of delandistrogene moxeparvovec in patients with Duchenne muscular dystrophy (DMD) show that ...
Patients with hereditary angioedema whose attacks impacted their larynx experienced on-demand relief within 1.29 hours with ...
Sahaj, who works for a Delhi-based firm from Rajkot as an AI Policy Researcher, will also make a presentation from the United Nations dias for international dignitaries and delegates from all over the ...
A new exhibition in New York brings together a diverse collection of posters reflecting the opposing ideologies surrounding ...
IceCure Medical Ltd. (NASDAQ: ICCM) ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive cryoablation technology that destroys tumors by freezing as an alternative to ...
Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak ® platform to develop drug-Fc conjugate (DFC) immunotherapies, today announced two upcoming ...
London's longest running art fair celebrates a major milestone with an exciting selection of exclusive editions and specially ...
Posters presented at the 2025 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference show that therapeutic ...
Dede Wilder has spent the past few months organizing community-centric art exhibitions at Walter's Café. Here’s what to ...
Create stunning visuals effortlessly with Google Gemini 2.0. Explore text-to-image, editing tools, and custom designs powered ...
The findings of this model support KIO-104 as a promising therapeutic candidate for both the prevention and treatment of PVR.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results